MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s40256-018-0290-3

Медицинская библиотека · American journal of cardiovascular drugs : drugs, devices, and other interventions · 2018

Association Between High-Dose Spironolactone and Decongestion in Patients with Acute Heart Failure: An Observational Retrospective Study.

Kapelios Chris J, Bonou Maria, Vogiatzi Paraskevi, Tzanis George, Mantzouratou Polyxeni, Lund Lars H, Barbetseas John

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Acute congestive heart failure (ACHF) is a state of severe, secondary hyperaldosteronism. Relief of congestion has prognostic implications. Our aim was to assess associations between high-dose spironolactone and (1) decongestion and (2) safety in patients with ACHF.

METHODS

The charts of 20 patients who were hospitalized with ACHF and received high doses of spironolactone (75-300 mg daily, group A) on top of standard of care (SOC) treatment were retrospectively studied and compared with the ones of 20 matched patients who received SOC treatment alone (group B).

RESULTS

The two groups were similar as per their baseline characteristics. Mean daily spironolactone dose was 143 ± 56 in group A vs. 25 ± 25 mg in group B (P < 0.001). Patients of group A demonstrated significantly greater daily urine output (median [25th, 75th percentile] 2.9 [2.3, 3.9] vs. 2.2 [1.9, 2.5] L/day, P = 0.009), daily weight loss (1.1 [0.9, 1.7] vs. 0.4 [0.2, 1.2] kg/day, P = 0.005) and total body weight loss (10.5 [7.3, 13.8] vs. 3.8 [3.0, 6.0] kg, P < 0.001) compared with patients of group B. There were no differences in incidence of renal dysfunction, hypokalemia and hyperkalemia.

CONCLUSION

In patients with ACHF, administration of high doses of spironolactone on top of SOC treatment appears safe and is associated with greater decongestion than SOC alone.

Для цитирования: Kapelios Chris J, Bonou Maria, Vogiatzi Paraskevi, Tzanis George, Mantzouratou Polyxeni, Lund Lars H, Barbetseas John. Association Between High-Dose Spironolactone and Decongestion in Patients with Acute Heart Failure: An Observational Retrospective Study.. American journal of cardiovascular drugs : drugs, devices, and other interventions. 2018. DOI: 10.1007/s40256-018-0290-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.